Study Finds Cost-sharing Assistance Programs Can Save Patients Thousands While Leading to Improved Adherence and Health Outcomes.
According to a recent analysis by IQVIA, chronically ill patients using cost-sharing assistance saved hundreds to thousands of dollars on [...]
Invoke a 1980’s Law to Lower Cost of Remdesivir for COVID-19, says 31 State Attorneys General
A coalition of attorneys general (AG) have requested the U.S. Department of Health and Human Services to invoke a federal [...]
Trump’s “Buy American” Executive Order Could Raise Drug Prices
Tensions escalate with pharma as President Trump signs an executive order (EO) today directing the federal government to buy certain [...]
Transforming legacy approaches to understanding drug costs: An Interview with HealthPlanView’s Nicole Espinoza
Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Nicole Espinoza, Vice President of Knowledge Management at Pharmspective, a Healthcare [...]
Paying for Specialty Pharmaceuticals: The Case of Injectable Oncology Drugs
John Schneider, Ph.D According to the American Cancer Society, the financial costs of cancer are high for both [...]